Intravenous Recombinant Human Mannose-Binding Lectin (rhMBL)

DRUG2 trials

Sponsors

Enzon Pharmaceuticals, Inc.

Conditions

Liver TransplantationMultiple Myeloma

Phase 1

Intravenous rhMBL in Patients With Multiple Myeloma Receiving Chemotherapy Followed by Stem Cell Transplant

CompletedNCT00388999

Enzon Pharmaceuticals, Inc.Multiple Myeloma

Start: 2006-09-30End: 2009-05-31Updated: 2011-12-05

A Multicenter Study Evaluating the Safety and Tolerability of Intravenous rhMBL in Liver Transplant Recipients.

TerminatedNCT00415311

Enzon Pharmaceuticals, Inc.Liver Transplantation

Start: 2006-12-31End: 2009-12-31Updated: 2011-08-09